Program
tebipenem
Also written as “TBPM-PI-HBr”, “TBP-PI-HBr” and “Tebipenem pivoxil hydrobromide (TBPM-PI-HBr)”.
Its studies are mostly in Urinary Tract Infections · Pyelonephritis · Renal Insufficiency, led by Spero Therapeutics.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Spero Therapeutics | 120 open or running | phase 3since Dec 22, 2018 | Oct 19, 2017 | none ahead |
Also a collaborator on its studies: GlaxoSmithKline, iqvia-pty-ltd, clinartis, covance, celerion and cpr-pharma-services-pty-ltd-australia.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Oct 19, 2017First study: phase 1 study in Healthy VolunteersFirst studyNCT03395249 · 124 enrolled · Australia
- Dec 22, 2018Phase 3 study in Complicated Urinary Tract InfectionNCT03788967 · 1,372 enrolled · United States, Bulgaria, Czechia and more
- Nov 14, 2019Phase 1 study in Renal InsufficiencyNCT04178577 · 39 enrolled · United States
- Jan 16, 2020Phase 1 study in TQT StudyNCT04238195 · 24 enrolled · United States
- Mar 16, 2020Phase 1 study in Healthy VolunteersNCT04376554 · 30 enrolled · Sweden
- Apr 9, 2020Phase 1 study in Healthy VolunteersNCT04368585 · 20 enrolled · United States
- Jun 4, 2020Phase 1 study in Healthy VolunteersNCT04421885 · 36 enrolled · United States
- Sep 17, 2020Phase 1 study in Healthy VolunteersNCT04625855 · 8 enrolled · United States
- Jan 4, 2021Phase 1 study in Healthy VolunteersNCT04710407 · 30 enrolled · United States
- May 3, 2023Phase 1 study in Healthy VolunteersNCT05856747 · 20 enrolled · United States
- Sep 22, 2023Phase 3 study in Urinary Tract InfectionsNCT06059846 · 1,690 enrolled · United States, Argentina, Bosnia and Herzegovina and more
- Dec 6, 2024Phase 1 study in Healthy ParticipantsNCT06727136 · 39 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 12 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06727136Healthy Participants · United States | 1 | Completed | Apr 22, 2025 | 39 |
| NCT06059846Urinary Tract Infections · United States, Argentina, Bosnia and Herzegovina and more | 3 | Completed | Jan 27, 2025 | 1,690 |
| NCT05856747Healthy Volunteers · United States | 1 | Completed | Jun 1, 2023 | 20 |
| NCT04710407Healthy Volunteers · United States | 1 | Completed | Mar 10, 2021 | 30 |
| NCT04625855Healthy Volunteers · United States | 1 | Completed | Oct 16, 2020 | 8 |
| NCT04421885Healthy Volunteers · United States | 1 | Completed | Jul 11, 2020 | 36 |
| NCT04368585Healthy Volunteers · United States | 1 | Completed | Aug 8, 2020 | 20 |
| NCT04376554Healthy Volunteers · Sweden | 1 | Completed | Apr 6, 2021 | 30 |
| NCT04238195TQT Study · United States | 1 | Completed | Feb 26, 2020 | 24 |
| NCT04178577Renal Insufficiency · United States | 1 | Completed | Sep 6, 2020 | 39 |
| NCT03788967Complicated Urinary Tract Infection · United States, Bulgaria, Czechia and more | 3 | Completed | May 20, 2020 | 1,372 |
| NCT03395249Healthy Volunteers · Australia | 1 | Completed | Aug 2, 2018 | 124 |
How it is read
Names in the registry
- “TBPM-PI-HBr”, 4 entries
- “TBP-PI-HBr”, 3 entries
- “Tebipenem pivoxil hydrobromide (TBPM-PI-HBr)”, 2 entries
- “Tebipenem pivoxil hydrobromide (TBPM-PI-HBr) - Reference”, 1 entry
- “Tebipenem pivoxil hydrobromide (TBPM-PI-HBr) - Test”, 1 entry
Conditions, from the studies’ own filings
- Urinary Tract Infections, 1 study
- Pyelonephritis, 1 study
- Renal Insufficiency, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.